A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT05783921 · UNKNOWN

Trial details

NCT number: NCT05783921
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Squamous Cell Carcinoma of the Head and Neck Metastatic Squamous Cell Carcinoma

Start date: 2023-05-23
Primary completion: 2024-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.